Skip to content

Tacrolimus 0.03% Eye Ointment - TGA Unlicensed Products


HL Pharma has exclusive distribution rights for numerous products and also specialises in sourcing and supply of products that are unlicensed in Australia.

These products may not have TGA registration or maybe an Australian product with supply issues. They are usually supplied under The Special Access Scheme (SAS) or Authorised Prescriber Scheme (APS). Other pathways to supply include Clinical Trial Supply.

For more product information on Tacrolimus 0.03% Eye Ointment and other brands such as; Entrak® and Talymus®, see below, or for further information on sourcing this product or any others, please don't hesitate to contact us.



Tacrolimus 0.03% Eye Ointment

What is Tacrolimus 0.03% eye ointment?

Tacrolimus eye ointment and eye drops and other brands including Entrak and Talymus are not licensed in Australia. 

Tacrolimus 0.03% eye ointment is used for the treatment of dry eye syndrome, keratoconjunctivitis sicca (KCS), and severe allergic conjunctival diseases.

Tacrolimus 0.1% eye drops are licensed in Japan, but not in Australia. Tacrolimus 0.03% Eye Ointment is manufactured in India under GMP (Good Manufacturing Practice) and is preservative-free. 

Tacrolimus Eye Drops Research Paper

NLM Tacrolimus Eye Drops Summary


Using Tacrolimus eye ointment and drops

The supply of unlicensed medicine from overseas in Australia is supplied under The Special Access Scheme.

 Tacrolimus 0.03% Eye Ointment is supplied under Special Access Scheme (SAS) B.

The SAS B system requires the prescriber to notify The TGA of the use.

TGA Special Access Scheme Information

If a prescriber requires many patients to use Tacrolimus 0.03% Eye Ointment or other brands including Entrak® and Talymus® they should apply for Authorised Prescriber Approval. 

HL Pharma is a specialist supplier of medicines from overseas. Please contact us for assistance and further information.